Researcher at Muljibhai Patel Urological Hospital Details Research in Refractory Anemia (Parvovirus B19 Infection as a Cause of Refractory Anemia in Kidney Transplant Recipients: A Case Series).

A study conducted at Muljibhai Patel Urological Hospital in Gujarat, India, has found that kidney transplant recipients are at a higher risk for parvovirus B19 (PVB19) infection, which can lead to refractory anemia and increased morbidity. The study reviewed the charts of patients who underwent kidney transplantation between May 2013 and March 2022 and found that 1.9% of patients had PVB19 disease, with symptoms including fatigue, fever, dyspnea, and myalgia. All patients developed anemia, and graft dysfunction was observed in 61.9% of patients. The primary treatment for PVB19 infection involves reducing immunosuppressants, especially antiproliferative agents. [Extracted from the article]